ClinicalTrials.Veeva

Menu

Catheter Ablation in Congenital Heart Disease: French National Prospective Registry (CATCH-Registry)

P

Paris Cardiovascular Research Center (Inserm U970)

Status

Unknown

Conditions

Arrhythmia
Congenital Heart Disease

Treatments

Procedure: Catheter ablation

Study type

Observational

Funder types

Other

Identifiers

NCT04202796
MR2C2001

Details and patient eligibility

About

Arrhythmias represent one of the main late complications in patients with congenital heart disease. Atrial arrhythmias are associated with a significant morbidity and are the first cause of urgent hospitalization, and sudden death from ventricular arrhythmias is a leading cause of death in this population.

The exponential increase of the number of patients with congenital heart disease and the improvement of ablative technologies are associated with a significant increase of the number of catheter ablation procedures.

Most of available studies are retrospective or include a limited number of patients.

The aim of this study is to assess the efficacy of catheter ablation in patients with congenital heart disease through a national prospective registry. Secondary objectives are i) to identify factors associated with catheter ablation efficacy in different cardiac defects, ii) to describe complications associated with catheter ablation in this specific population, and iii) to assess the impact of catheter ablation on quality of life of patients with congenital heart disease.

Enrollment

300 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients with congenital heart disease referred for catheter ablation

Exclusion criteria

  • Absence of patient's consent
  • Patient under guardianship or curatorship
  • Pregnant woman

Trial contacts and locations

1

Loading...

Central trial contact

Victor Waldmann, MD, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems